Key Takeaway: Vivani Medical has appointed Daniel Bradbury to its Board of Directors. His extensive experience in the biopharma industry is expected to contribute positively to the company's strategic direction. This appointment follows a series of leadership changes aimed at strengthening the company's governance.
Price reaction · baseline $2.15 (2024-03-05 close) · hit pre-market · clean, no other VANI news in the window
day 0 close
+2.8%
Market Sentiment Analysis
POSITIVE FACTORS
Daniel Bradbury brings extensive experience to the board.
The appointment may enhance strategic direction for Vivani Medical.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Cash runway
~10 mo
Medium dilution risk
Lead asset
Semaglutide
Phase 1 · Obesity & Overweight
Full Press Release Details
Blog Post
| March 6, 2024
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
Read More
Previous Article
Next Article
Blog Navigation
Frequently Asked Questions
Who has been appointed to Vivani Medical's Board?
Daniel Bradbury has been appointed to Vivani Medical's Board of Directors.
What is the significance of this appointment?
Bradbury's extensive experience is expected to enhance the company's strategic direction.